Filer Snapshot

ModernaTX, Inc.

CIK 0001962626. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity Type

Company

Total Filings

3

Latest Filing

24 Mar 2023

Industry

n/a

Follow future filing-backed changes

Save this filer to return when a new filing changes the portfolio, large-stake, insider, or company context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Best next click

Start with the summary below, then verify the strongest source-backed page for this filer.

  • Open 13F if you want portfolio holdings.
  • Open 13D/G or insider pages only when this CIK has those rows.
Source: SEC Schedule 13D/G

SC 13G filed on 24 Mar 2023 for CIK 0001962626.

View Source Filing
Business address
200 Technology Square, Cambridge, MA, 02139
Top ownership issuers
CARM
State of incorporation
DE
Fiscal year end
31 December

Filer intelligence

What SEC filings say about ModernaTX, Inc.

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Forms 3/4/5 show insider context for CARM worth $2.97M.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 1 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

CARM

07 Mar 2023 ยท 10% owner

$2.97M

Latest update

What changed recently for ModernaTX, Inc.

Ownership report updated

Latest ownership report period: 07 Mar 2023. Open the source-backed page to inspect the fresh filing or facts context.

Update date

13 Mar 2023

Page type

Ownership filings

Latest period

07 Mar 2023

Ownership context was refreshed from SEC Forms 3/4/5 filed on 13 Mar 2023.

Benchmark Context

Benchmark context for this company

ModernaTX, Inc. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest ownership report period: 07 Mar 2023. That gives you a fresh baseline before you compare this company with peers.

  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

SEC filing record

CIK 0001962626 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
3
First seen
13 Mar 2023
Latest filing
24 Mar 2023
Entity
Company

Latest Filings

Recent SEC filings for ModernaTX, Inc. with direct links to document and filing folders.

SC 13G

SC 13G

Filing date
24 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SCHEDULE 13G

Filing date
13 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-36296

FORM 3

Filing date
13 Mar 2023
Reporting date
07 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .